Inflammation, negative nitrogen balance, and outcome after aneurysmal subarachnoid hemorrhage

Neurology

Volumn 84, Issue 7, 2015, Pages 680-687

  Badjatia, Neeraj ^a   Monahan, Aimee ^b   Carpenter, Amanda ^b   Zimmerman, Jacqueline ^b   Schmidt, J Michael ^b   Claassen, Jan ^b   Connolly, E Sander ^b   Mayer, Stephan A ^b   Karmally, Wahida ^c   Seres, David ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NEUROLOGICAL INSTITUTE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; DEXAMETHASONE; PREALBUMIN; NITROGEN;

ADULT; ARTICLE; BODY MASS; BRAIN ARTERY ANEURYSM; BRAIN ISCHEMIA; CALORIC INTAKE; CLINICAL ASSESSMENT; FEMALE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NEGATIVE NITROGEN BALANCE; NITROGEN BALANCE; NUTRITIONAL STATUS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN DEGRADATION; RANKIN SCALE; RESTING ENERGY EXPENDITURE; SUBARACHNOID HEMORRHAGE; TASK PERFORMANCE; COMPLICATION; CROSS INFECTION; ENERGY METABOLISM; INTRACRANIAL ANEURYSM; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROGNOSIS; REST;

C-REACTIVE PROTEIN; CROSS INFECTION; ENERGY INTAKE; ENERGY METABOLISM; FEMALE; HUMANS; INFLAMMATION; INTRACRANIAL ANEURYSM; MALE; MIDDLE AGED; NITROGEN; PREALBUMIN; PROGNOSIS; PROSPECTIVE STUDIES; REST; SUBARACHNOID HEMORRHAGE;

EID: 84923251393     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001259     Document Type: Article

References (43)

1. Bederson JB, Connolly ES Jr, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009;40:994-1025.
2. Frontera JA, Fernandez A, Schmidt JM, et al. Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke 2009;40: 1963-1968.
3. Frontera JA, Fernandez A, Schmidt JM, et al. Impact of nosocomial infectious complications after subarachnoid hemorrhage. Neurosurgery 2008;62:80-87; discussion 87.
4. Naidech AM, Bendok BR, Tamul P, et al. Medical complications drive length of stay after brain hemorrhage: a cohort study. Neurocrit Care 2009;10:11-19.
5. Wartenberg KE, Schmidt JM, Claassen J, et al. Impact of medical complications on outcome after subarachnoid hemorrhage [see comment]. Crit Care Med 2006;34: 617-623; quiz 624.
6. Badjatia N, Fernandez L, Schlossberg MJ, et al. Relationship between energy balance and complications after subarachnoid hemorrhage. JPEN J Parenter Enteral Nutr 2010;34:64-69.
7. Singer P, Shapiro H, Theilla M, Anbar R, Singer J, Cohen J. Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective. Intensive Care Med 2008;34: 1580-1592.
8. Kasuya H, Kawashima A, Namiki K, Shimizu T, Takakura K. Metabolic profiles of patients with subarachnoid hemorrhage treated by early surgery. Neurosurgery 1998;42:1268-1274; discussion 1274-1265.
9. Esper DH, Coplin WM, Carhuapoma JR. Energy expenditure in patients with nontraumatic intracranial hemorrhage. JPEN J Parenter Enteral Nutr 2006;30:71-75.
10. Wartenberg KE, Mayer SA. Medical complications after subarachnoid hemorrhage: new strategies for prevention and management. Curr Opin Crit Care 2006;12:78-84.
11. Diringer MN, Bleck TP, Hemphill IJC, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the neurocritical care society's multidisciplinary consensus conference. Neurocrit Care 2011;15:211-240.
12. Cerra FB, Benitez MR, Blackburn GL, et al. Applied nutrition in ICU patients: a consensus statement of the American College of Chest Physicians. Chest 1997;111: 769-778.
13. Yahia AM, Kirmani JF, Qureshi AI, Guterman LR, Hopkins LN. The safety and feasibility of continuous intravenous magnesium sulfate for prevention of cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Neurocrit Care 2005;3:16-23.
14. Vergouwen MD, Vermeulen M, van Gijn J, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke 2010;41:2391-2395.
15. O'Grady NP, Barie PS, Bartlett JG, et al. Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med 2008;36:1330-1349.
16. Documents ATS. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
17. Badjatia N, Carpenter A, Fernandez L, et al. Relationship between C-reactive protein, systemic oxygen consumption, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke 2011;42:2436-2442.
18. Badjatia N, Seres D, Carpenter A, et al. Free fatty acids and delayed cerebral ischemia after subarachnoid hemorrhage. Stroke 2012;43:691-696.
19. de Haan R, Limburg M, Bossuyt P, van der Meulen J, Aaronson N. The clinical meaning of Rankin "handicap" grades after stroke. Stroke 1995;26:2027-2030.
20. American Physiological Society, World Medical Association General Assembly. Guiding principles for research involving animals and human beings. Am J Physiol Cell Physiol 2002;282:3.
21. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968;28:14-20.
22. Frontera JA, Claassen J, Schmidt JM, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery 2006;59:21-27; discussion 21-27.
23. Drolz A, Wewalka M, Horvatits T, et al. Gender-specific differences in energy metabolism during the initial phase of critical illness. Eur J Clin Nutr 2014;68:707-711.
24. Schlein KM, Coulter SP. Best practices for determining resting energy expenditure in critically ill adults. Nutr Clin Pract 2014;29:44-55.
25. Moussouttas M, Lai EW, Dombrowski K, et al. CSF catecholamine profile in subarachnoid hemorrhage patients with neurogenic cardiomyopathy. Neurocrit Care 2011; 14:401-406.
26. Espiner EA, Leikis R, Ferch RD, et al. The neuro-cardioendocrine response to acute subarachnoid haemorrhage. Clin Endocrinol 2002;56:629-635.
27. Sehba FA, Bederson JB. Mechanisms of acute brain injury after subarachnoid hemorrhage. Neurol Res 2006;28: 381-398.
28. Jeon YT, Lee JH, Lee H, et al. The postoperative C-reactive protein level can be a useful prognostic factor for poor outcome and symptomatic vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 2012;24:317-324.
29. Romero FR, Cataneo DC, Cataneo AJ. C-reactive protein and vasospasm after aneurysmal subarachnoid hemorrhage. Acta Cir Bras 2014;29:340-345.
30. Ferrie S, Allman-Farinelli M. Commonly used "nutrition" indicators do not predict outcome in the critically ill: a systematic review. Nutr Clin Pract 2013;28:463-484.
31. Koretz RL. Death, morbidity and economics are the only end points for trials. Proc Nutr Soc 2005;64:277-284.
32. Xie Q, Zhou Y, Xu Z, et al. The ratio of CRP to prealbumin levels predict mortality in patients with hospitalacquired acute kidney injury. BMC Nephrol 2011;12:30.
33. Pinilla JC, Hayes P, Laverty W, Arnold C, Laxdal V. The C-reactive protein to prealbumin ratio correlates with the severity of multiple organ dysfunction. Surgery 1998;124: 799-805; discussion 805-796.
34. Stapleton RD, Jones N, Heyland DK. Feeding critically ill patients: what is the optimal amount of energy? Crit Care Med 2007;35:S535-S540.
35. Rice TL. Energy provided by propofol infusion. Am J Health Syst Pharm 2008;65:2090-2091.
36. Martindale RG, McClave SA, Vanek VW, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition: executive summary. Crit Care Med 2009;37:1757-1761.
37. Behara AS, Peterson SJ, Chen Y, Butsch J, Lateef O, Komanduri S. Nutrition support in the critically ill: a physician survey. JPEN J Parenter Enteral Nutr 2008;32: 113-119.
38. de Rooij NK, Rinkel GJ, Dankbaar JW, Frijns CJ. Delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review of clinical, laboratory, and radiological predictors. Stroke 2013;44:43-54.
39. Weijs PJ, Wischmeyer PE. Optimizing energy and protein balance in the ICU. Curr Opin Clin Nutr Metab Care 2013;16:194-201.
40. Schweizer TA, Al-Khindi T, Macdonald RL. Mini-Mental State Examination versus Montreal Cognitive Assessment: rapid assessment tools for cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. J Neurol Sci 2012;316:137-140.
41. Tso M, Macdonald RL. A need for a standardized cognitive outcome measure in subarachnoid hemorrhage clinical studies. World Neurosurg 2014;81:252-254.
42. Shirao S, Fujisawa H, Kudo A, et al. Inhibitory effects of eicosapentaenoic acid on chronic cerebral vasospasm after subarachnoid hemorrhage: possible involvement of a sphingosylphosphorylcholine-rho-kinase pathway. Cerebrovasc Dis 2008;26:30-37.
43. Yoneda H, Shirao S, Kurokawa T, Fujisawa H, Kato S, Suzuki M. Does eicosapentaenoic acid (EPA) inhibit cerebral vasospasm in patients after aneurysmal subarachnoid hemorrhage? Acta Neurol Scand 2008;118: 54-59.